Reduced maximal inhibition in phenotypic susceptibility assays indicates that viral strains resistant to the CCR5 antagonist maraviroc utilize inhibitor-bound receptor …
M Westby, C Smith-Burchnell, J Mori, M Lewis… - Journal of …, 2007 - Am Soc Microbiol
Maraviroc is a CCR5 antagonist in clinical development as one of a new class of
antiretrovirals targeting human immunodeficiency virus type 1 (HIV-1) coreceptor binding …
antiretrovirals targeting human immunodeficiency virus type 1 (HIV-1) coreceptor binding …
Reduced maximal inhibition in phenotypic susceptibility assays indicates that viral strains resistant to the CCR5 antagonist maraviroc utilize inhibitor-bound receptor …
M Westby, C Smith-Burchnell, J Mori… - Journal of …, 2007 - pubmed.ncbi.nlm.nih.gov
Maraviroc is a CCR5 antagonist in clinical development as one of a new class of
antiretrovirals targeting human immunodeficiency virus type 1 (HIV-1) coreceptor binding …
antiretrovirals targeting human immunodeficiency virus type 1 (HIV-1) coreceptor binding …
[引用][C] Reduced maximal inhibition in phenotypic susceptibility assays indicates that viral strains resistant to the CCR5 antagonist maraviroc utilize inhibitor-bound …
M WESTBY, C SMITH-BURCHNELL, J MORI… - Journal of …, 2007 - pascal-francis.inist.fr
Reduced maximal inhibition in phenotypic susceptibility assays indicates that viral strains
resistant to the CCR5 antagonist maraviroc utilize inhibitor-bound receptor for entry CNRS Inist …
resistant to the CCR5 antagonist maraviroc utilize inhibitor-bound receptor for entry CNRS Inist …
[HTML][HTML] Reduced Maximal Inhibition in Phenotypic Susceptibility Assays Indicates that Viral Strains Resistant to the CCR5 Antagonist Maraviroc Utilize Inhibitor …
M Westby, C Smith-Burchnell, J Mori, M Lewis… - Journal of …, 2007 - ncbi.nlm.nih.gov
Maraviroc is a CCR5 antagonist in clinical development as one of a new class of
antiretrovirals targeting human immunodeficiency virus type 1 (HIV-1) coreceptor binding …
antiretrovirals targeting human immunodeficiency virus type 1 (HIV-1) coreceptor binding …
Reduced maximal inhibition in phenotypic susceptibility assays indicates that viral strains resistant to the CCR5 antagonist maraviroc utilize inhibitor-bound receptor …
M Westby, C Smith-Burchnell, J Mori, M Lewis… - 2007 - cabidigitallibrary.org
Maraviroc is a CCR5 antagonist in clinical development as one of a new class of
antiretrovirals targeting human immunodeficiency virus type 1 (HIV-1) coreceptor binding …
antiretrovirals targeting human immunodeficiency virus type 1 (HIV-1) coreceptor binding …
Reduced Maximal Inhibition in Phenotypic Susceptibility Assays Indicates that Viral Strains Resistant to the CCR5 Antagonist Maraviroc Utilize Inhibitor-Bound …
M Westby, C Smith-Burchnell, J Mori, M Lewis… - Journal of …, 2007 - cir.nii.ac.jp
抄録< jats: title> ABSTRACT</jats: title>< jats: p> Maraviroc is a CCR5 antagonist in clinical
development as one of a new class of antiretrovirals targeting human immunodeficiency …
development as one of a new class of antiretrovirals targeting human immunodeficiency …
[PDF][PDF] Reduced Maximal Inhibition in Phenotypic Susceptibility Assays Indicates that Viral Strains Resistant to the CCR5 Antagonist Maraviroc Utilize Inhibitor-Bound …
M Westby, C Smith-Burchnell, J Mori… - JOURNAL OF …, 2007 - academia.edu
MATERIALS AND METHODS Compounds, cells, and viruses. Enfuvirtide was synthesized
by NeoMPS (Strasbourg, France). Maraviroc (UK427, 857), SCH-C, aplaviroc, efavirenz, and …
by NeoMPS (Strasbourg, France). Maraviroc (UK427, 857), SCH-C, aplaviroc, efavirenz, and …
Reduced maximal inhibition in phenotypic susceptibility assays indicates that viral strains resistant to the CCR5 antagonist maraviroc utilize inhibitor-bound receptor …
M Westby, C Smith-Burchnell, J Mori, M Lewis… - Journal of …, 2006 - europepmc.org
Maraviroc is a CCR5 antagonist in clinical development as one of a new class of
antiretrovirals targeting human immunodeficiency virus type 1 (HIV-1) coreceptor binding …
antiretrovirals targeting human immunodeficiency virus type 1 (HIV-1) coreceptor binding …
[引用][C] Reduced maximal inhibition in phenotypic susceptibility assays indicates that viral strains resistant to the CCR5 antagonist maraviroc utilize inhibitor-bound …
M WESTBY - J. Virol., 2007 - cir.nii.ac.jp
Reduced maximal inhibition in phenotypic susceptibility assays indicates that viral strains
resistant to the CCR5 antagonist maraviroc utilize inhibitor-bound receptor for entry | CiNii …
resistant to the CCR5 antagonist maraviroc utilize inhibitor-bound receptor for entry | CiNii …